Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Invested Capital (2018 - 2025)

Dna X filings provide 8 years of Return on Invested Capital readings, the most recent being 0.02% for Q3 2025.

  • On a quarterly basis, Return on Invested Capital rose 3.0% to 0.02% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.02%, a 3.0% increase, with the full-year FY2024 number at 0.0%, changed 0.0% from a year prior.
  • Return on Invested Capital hit 0.02% in Q3 2025 for Dna X, up from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.02% in Q3 2025 to a low of 0.08% in Q4 2022.
  • Median Return on Invested Capital over the past 5 years was 0.01% (2024), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Invested Capital: decreased -5bps in 2022 and later grew 8bps in 2023.
  • Dna X's Return on Invested Capital stood at 0.02% in 2021, then crashed by -224bps to 0.08% in 2022, then skyrocketed by 100bps to 0.0% in 2023, then plummeted by -36275bps to 0.01% in 2024, then soared by 360bps to 0.02% in 2025.
  • The last three reported values for Return on Invested Capital were 0.02% (Q3 2025), 0.0% (Q2 2025), and 0.0% (Q1 2025) per Business Quant data.